IFAM
ARNA

Institutional & Family Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Institutional & Family Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-26
Closed -$2K – 948
2020
Q3 		$2K Hold
26
– – ﹤0.01% 752
2020
Q2 		$2K Sell
26
-8
-24% -$440 ﹤0.01% 735
2020
Q1 		$1K Hold
34
– – ﹤0.01% 795
2019
Q4 		$2K Hold
34
– – ﹤0.01% 777
2019
Q3 		$2K Hold
34
– – ﹤0.01% 747
2019
Q2 		$2K Hold
34
– – ﹤0.01% 763
2019
Q1 		$2K Buy
+34
New +$1.56K ﹤0.01% 753

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Institutional & Family Asset Management's ARNA Position: Q4 2020 in Review

Institutional & Family Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2020, closing a stake of 26 shares — an estimated $2K sold.

Institutional & Family Asset Management first reported a position in ARNA in Q1 2019 and held it in 7 quarters. The position peaked at $2K in Q3 2020. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

  • Institutional & Family Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • Institutional & Family Asset Management sold 26 Arena Pharmaceuticals Inc shares in Q4 2020, an estimated $2K.
  • Institutional & Family Asset Management first reported a position in Arena Pharmaceuticals Inc in Q1 2019 and held it in 7 quarters.
  • Institutional & Family Asset Management's Arena Pharmaceuticals Inc position peaked at $2K in Q3 2020.
  • 254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on Institutional & Family Asset Management's 13F filing for Q4 2020, filed 3 Feb 2021.